Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Joinpoint"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Trends in gastrointestinal cancer incidence in Iran, 2001-2010: a joinpoint analysis
Mehdi Darabi, Mohsen Asadi Lari, Seyed Abbas Motevalian, Ali Motlagh, Shahram Arsang-Jang, Maryam Karimi Jaberi
Epidemiol Health. 2016;38:e2016056.   Published online December 5, 2016
DOI: https://doi.org/10.4178/epih.e2016056
  • 15,675 View
  • 333 Download
  • 26 Web of Science
  • 17 Crossref
AbstractAbstract PDF
Abstract
OBJECTIVES
The main purpose of this study was to evaluate changes in the time trends of stomach, colorectal, and esophageal cancer during the past decade in Iran.
METHODS
Cancer incidence data for the years 2001 to 2010 were obtained from the cancer registration of the Ministry of Health. All incidence rates were directly age-standardized to the world standard population. In order to identified significant changes in time trends, we performed a joinpoint analysis. The annual percent change (APC) for each segment of the trends was then calculated.
RESULTS
The incidence of stomach cancer increased from 4.18 and 2.41 per 100,000 population in men and women, respectively, in 2001 to 17.06 (APC, 16.7%) and 8.85 (APC, 16.2%) per 100,000 population in 2010 for men and women, respectively. The corresponding values for colorectal cancer were 2.12 and 2.00 per 100,000 population for men and women, respectively, in 2001 and 11.28 (APC, 20.0%) and 10.33 (APC, 20.0%) per 100,000 in 2010. For esophageal cancer, the corresponding increase was from 3.25 and 2.10 per 100,000 population in 2001 to 5.57 (APC, 12.0%) and 5.62 (APC, 11.2%) per 100,000 population among men and women, respectively. The incidence increased most rapidly for stomach cancer in men and women aged 80 years and older (APC, 23.7% for men; APC, 18.6% for women), for colorectal cancer in men aged 60 to 69 years (APC, 24.2%) and in women aged 50 to 59 years (APC, 25.1%), and for esophageal cancer in men and women aged 80 years and older (APC, 17.5% for men; APC,15.3% for women) over the period of the study.
CONCLUSIONS
The incidence of gastrointestinal cancer significantly increased during the past decade. Therefore, monitoring the trends of cancer incidence can assist efforts for cancer prevention and control.
Summary

Citations

Citations to this article as recorded by  
  • Prevalence, trends, and characteristics of metabolic dysfunction-associated steatotic liver disease among the US population aged 12–79 years
    Tsung-Hua Shen, Chung-Hsuen Wu, Yuan-Wen Lee, Chun-Chao Chang
    European Journal of Gastroenterology & Hepatology.2024; 36(5): 636.     CrossRef
  • Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016
    Yu-Chien Chang, Hsin-Yi Huang, Tsung-Hua Shen, Chung-Hsuen Wu
    Medicine.2023; 102(22): e33828.     CrossRef
  • THE EFFECT OF PASSIVE MUSIC THERAPY ON THE QUALITY OF LIFE OF FAMILY CAREGIVERS OF CANCER PATIENTS UNDERGOING CHEMOTHERAPY REFERRING TO IMAM KHOMEINI UNIVERSITY HOSPITAL AT URMIA, IRAN IN 2022
    Samereh Eghtedar, Moloud Radfar, Yasin Shafipour, Vahid Alinejad
    Nursing and Midwifery Journal.2023; 20(12): 1014.     CrossRef
  • Investigating Trends of Incidence Rates of Esophageal Cancer Divided by Squamous Cell Carcinoma and Adenocarcinoma in Southern Iran: a 10-Year Experience
    Mahnaz Hosseini-Bensenjan, Hossein Molavi Vardanjani, Sezaneh Haghpanah, Zahra Khosravizadegan, Kamran Bagheri-Lankarani
    Journal of Gastrointestinal Cancer.2022; 53(1): 230.     CrossRef
  • Gastrointestinal cancer prevention policies: A qualitative systematic review and meta-synthesis
    Neda Kabiri, Rahim Khodayari-zarnaq, Manouchehr Khoshbaten, Ali Janati
    International Journal of Preventive Medicine.2022; 13(1): 8.     CrossRef
  • A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma
    Rajabali Daroudi, Azin Nahvijou, Mohammad Arab, Ahmad Faramarzi, Bita Kalaghchi, Ali Akbari Sari, Javad Javan-Noughabi
    Cost Effectiveness and Resource Allocation.2022;[Epub]     CrossRef
  • Significant Association of Variable Number Tandem Repeat Polymorphism rs58335419 in the MIR137 Gene With the Risk of Gastric and Colon Cancers
    Pegah Jafari, Sedighe Baghernia, Mehdi Moghanibashi, Parisa Mohamadynejad
    British Journal of Biomedical Science.2022;[Epub]     CrossRef
  • Mortality Trends of Gastrointestinal, Liver, and Pancreaticobiliary Diseases: A Hospital-Based Prospective Study in the Southeast of Iran
    Mohammad Javad Zahedi, Sara Shafieipour, Mohammad Mahdi Hayatbakhsh Abbasi, Mohsen Nakhaie, Mohammad Rezaei Zadeh Rukerd, Mohammad Mehdi Lashkarizadeh, Farbood Noorbini, Mohammad Hasan Baghaei, Abbas Pourjafari, Ebrahim Aminian, Fatemeh Karami Robati, Aza
    Middle East Journal of Digestive Diseases.2022; 14(4): 404.     CrossRef
  • Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran)
    Abbas Ali Ramazani, Ensiyeh Norozi, Hassan AmirabadiZadeh, Ali Reza Ehteshampour, Hamid Salehiniya
    Journal of Gastrointestinal Cancer.2021; 52(1): 187.     CrossRef
  • Incidence and Risk Factors of Colorectal Cancer in the Iranian Population: a Systematic Review
    Hossein Mozafar Saadati, Batool Okhovat, Farzad Khodamoradi
    Journal of Gastrointestinal Cancer.2021; 52(2): 414.     CrossRef
  • Trend of Gastric Cancer Incidence in an Area Located in the Center of Iran: 2009–2014
    Rahmatollah Moradzadeh, Ali Arash Anoushirvani
    Journal of Gastrointestinal Cancer.2020; 51(1): 159.     CrossRef
  • Descriptive Epidemiology of Brain and Central Nervous System Tumours: Results from Iran National Cancer Registry, 2010-2014
    Amir Salimi, Alireza Zali, Amir Saeid Seddighi, Afsoun Seddighi, Shakila Meshkat, Morteza Hosseini, Amir Nikouei, Mohammad Esmaeil Akbari
    Journal of Cancer Epidemiology.2020; 2020: 1.     CrossRef
  • Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review


    Khadijeh Kalan Farmanfarma, Neda Mahdavifar, Soheil Hassanipour, Hamid Salehiniya
    Clinical and Experimental Gastroenterology.2020; Volume 13: 511.     CrossRef
  • Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001–2015
    Rahmatollah Moradzadeh, Parvaneh Golmohammadi, Bahman Ghaitasi, Haidar Nadrian, Athareh Najafi
    Journal of Gastrointestinal Cancer.2019; 50(3): 507.     CrossRef
  • A 12-year trend analysis of the incidence of gastrointestinal cancers in East Azerbaijan: last updated results of an ongoing population-based cancer registry
    Mohammad Hossein Somi, Roya Dolatkhah, Sepideh Sepahi, Mina Belalzadeh, Shahnaz Naghashi, Mohammad Asghari Jafarabadi
    BMC Cancer.2019;[Epub]     CrossRef
  • Trends and risk factors of gastric cancer in Iran (2005–2010)
    Sedigheh Rastaghi, Tohid Jafari-Koshki, Behzad Mahaki, Yousef Bashiri, Kamran Mehrabani, Ali Soleimani
    International Journal of Preventive Medicine.2019; 10(1): 79.     CrossRef
  • Helicobacter pylori cagL amino acid polymorphism D58E59 pave the way toward peptic ulcer disease while N58E59 is associated with gastric cancer in north of Iran
    Mina Rezaee Cherati, Javad Shokri-Shirvani, Ahmad Karkhah, Ramzan Rajabnia, Hamid Reza Nouri
    Microbial Pathogenesis.2017; 107: 413.     CrossRef

Epidemiol Health : Epidemiology and Health